Cesar Arias
Endocrinology, Diabetes & Metabolism · Amarillo, TXNPI 1942393871
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,096 and has fallen 98.4% since, to $17 in 2023. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in TX, where the typical reported total is $2,974.
Across 228 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$538
- AbbVie$446
- Sanofi-aventis U.S. LLC$381
- Lilly USA, LLC$324
- Dexcom, Inc.$273
- Boehringer Ingelheim$269
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $538 |
| AbbVie | 29 | $446 |
| Sanofi-aventis U.S. LLC | 24 | $381 |
| Lilly USA, LLC | 21 | $324 |
| Dexcom, Inc. | 16 | $273 |
| Boehringer Ingelheim | 18 | $269 |
| Johnson & Johnson | 15 | $195 |
| Xeris Pharmaceuticals, Inc. | 12 | $185 |
| Mannkind Corporation | 10 | $180 |
| Abbott | 9 | $158 |
| Amgen | 9 | $141 |
| Radius Health, Inc. | 7 | $136 |
| Recordati_rare_diseases_inc. | 1 | $73 |
| AstraZeneca(2 entities) | 4 | $70 |
| Pfizer | 3 | $44 |
| Amarin Pharma, Inc. | 2 | $38 |
| Merck | 3 | $36 |
| Corcept Therapeutics | 2 | $34 |
| Medtronic | 2 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Companion Medical, Inc. | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Insulet Corporation | 1 | $13 |
How this compares
$3,611 in reported general payments places this provider in the 50th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.
See all endocrinology, diabetes & metabolism providers in Texas →
Other endocrinology, diabetes & metabolism in Amarillo
- Kenny BrantleyAmarillo$128K
- Lance SloanLufkin$1.7M
- Pablo MoraDallas$1.3M
- Robert HoodBeaumont$1.3M
- Eduardo LunaEdinburg$1.3M
- Steve FordanDallas$1.2M
- Rosemarie LajaraPlano$1.2M
- Saleemah FahmiDallas$1.2M
- Julio RosenstockDallas$1.2M
- Rocio HarbisonHouston$989K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.